Related Experiment Video
Updated: Jun 13, 2026

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
Published on: January 31, 2025
Ca 2+ -dependent autophagy is enhanced by the pharmacological agent PK11195
Annalisa Gastaldello1, Holly Callaghan, Priya Gami
1Royal Veterinary College, University of London, London UK.
Abstract:
The 1-(2-Chlorophenyl-N-methylpropyl)-3-isoquinolinecarboxamide, PK11195, is a proven enhancer of apoptotic cell death in a variety of cellular models. Recently, we have shown that by targeting the oncogene Bcl-2, PK11195 increases the [Ca ( 2+) ] in the Endoplasmic Reticulum ([Ca ( 2+) ]er) as well as IP3 induced mitochondrial ([Ca ( 2+) ]m) and cytosolic ([Ca ( 2+) ]c) Ca ( 2+) transients in HeLa cervix carcinoma cells. Here, in the same cells, we have investigated PK11195 contribution to models of pharmacologically induced macroautophagy. To do so, we have monitored the pattern of LC3 (the mammalian orthologue of yeast Atg8) distribution and post transcriptional modifications after challenging with Ca ( 2+) -dependent (ATP, Vitamin D3) and independent (Rapamycin and H 2O 2) stimuli for autophagy execution. We found that PK11195 plays a pro-autophagy role if associated with ATP and Vitamin D3 to be ineffective if co-incubated with Rapamycin and H 2O 2. Notably, Bcl-2 deletion abolished PK11195 effects thus suggesting a selective way of action against the oncogene. By these means, PK11195 is proposed as facilitator of Ca ( 2+) mediated autophagy and tool to ascertain the Bcl-2 contribution to the onset and unfolding of this essential catabolic process for cellular homeostasis.
Insights
PK11195 enhances calcium-mediated autophagy by targeting the Bcl-2 oncogene, acting as a tool to study cellular homeostasis and autophagy. This compound
Area of Science:
- Cell Biology
- Molecular Biology
- Oncology
Background:
- PK11195, a known apoptosis enhancer, targets the Bcl-2 oncogene.
- PK11195 modulates intracellular calcium levels, including in the endoplasmic reticulum, mitochondria, and cytosol.
- The role of PK11195 in pharmacologically induced macroautophagy remains to be fully elucidated.
Purpose of the Study:
- To investigate the contribution of PK11195 to models of pharmacologically induced macroautophagy.
- To determine the effect of PK11195 on macroautophagy in HeLa cervix carcinoma cells.
- To ascertain the role of Bcl-2 in PK11195-mediated autophagy.
Main Methods:
- Monitoring LC3 distribution and post-transcriptional modifications.
- Utilizing calcium-dependent (ATP, Vitamin D3) and independent (Rapamycin, H2O2) autophagy stimuli.
- Employing Bcl-2 deletion models to assess PK11195's mechanism of action.
Main Results:
- PK11195 demonstrated a pro-autophagy role when combined with ATP and Vitamin D3.
- PK11195 was ineffective in promoting autophagy with Rapamycin and H2O2.
- Bcl-2 deletion abrogated the effects of PK11195, indicating a selective action against Bcl-2.
Conclusions:
- PK11195 facilitates calcium-mediated autophagy.
- PK11195 serves as a valuable tool for investigating Bcl-2's role in autophagy.
- Understanding PK11195's mechanism can provide insights into cellular homeostasis and catabolic processes.
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
cAMP-dependent Protein Kinase Pathways
PI3K/mTOR/AKT Signaling Pathway
Lysosomal Hydrolases

